Impact of Fluocinonide 0,05% in Oral Lichen Planus

Summary

A double-blind placebo-controlled trial is conducted in order to evaluate the efficacy of Fluocinonide 0,05% and determinate the statistical significance of the outcome variables. Oral cavity lichen is a chronic inflammatory condition affecting the mucosa of the oral cavity , which significantly reduces the quality of life of affected individuals.

Timeline

Start

2023-08-20

Primary completion

2024-02-28

Completion

2024-02-28

Drugs

Indications